Attoplex Inc., a company specialising in in vitro diagnostic (IVD) medical devices, has signed a Memorandum of Understan...
South Korea-based Lunit, a leading provider of artificial intelligence (AI) for cancer diagnostics and therapeutics, has...
South Korea-based Seegene Inc., a global leader in molecular diagnostics (MDx) solutions, has announced the launch of ST...
Sciex, a global leader in life science analytical technologies, has signed a strategic Memorandum of Understanding (MoU)...
SK bioscience, a global innovative vaccine and biotech company based in South Korea, has secured a large-scale co...
South Korea-based SK Biopharm has signed a strategic Memorandum of Understanding (MoU) with AI corporation PhnyX Lab in ...
US-based Quanterix Corporation, a company fueling scientific discovery through ultrasensitive biomarker detection, has a...
Japan-based Ono Pharmaceutical Co., and Vertex Pharmaceuticals Incorporated, in the US, have announced an exclusive coll...
Novogene, a global leader in next-generation sequencing (NGS) and multi-omics solutions, has announced the establishment...
Celltrion UK has officially opened its new UK headquarters at the Charter Building in Uxbridge, UK, reinforcing the comp...
Lotte Biologics, Axcelead Drug Discovery Partners, Inc., and Kanaph Therapeutics Inc. have signed a tripartite Memorandu...
South Korea-based Samsung Biologics, a leading contract development and manufacturing organisation (CDMO), has announced...
South Korea-based Mezzion Pharma Co., a leader in rare disease therapeutics, has announced the expansion of its udenafil...
Cytiva, a Danaher company and global life sciences leader, has completed significant expansion projects in several locat...
Swedish biotech company Salipro Biotech AB has entered into a research collaboration with South Korea headquartered Daew...
AriBio Co., a South Korean biopharmaceutical company specialising in neurodegenerative diseases, and a Swiss pharmaceuti...
US-based Seer, Inc. and Korea University have announced the launch of a population-level study aimed at identifying nove...
MarkHerz Inc., a South Korea-based biotechnology startup specialising in AAV-based gene therapies targeting cardiovascul...
